<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02238665</url>
  </required_header>
  <id_info>
    <org_study_id>HN-0005</org_study_id>
    <nct_id>NCT02238665</nct_id>
  </id_info>
  <brief_title>CLE for Differential Diagnosis of IBD</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Erlangen-Nürnberg Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Erlangen-Nürnberg Medical School</source>
  <brief_summary>
    <textblock>
      Differential diagnosis between Ulcerative Colitis (UC) and Crohn's disease (CD) is of pivotal&#xD;
      importance for the management of Inflammatory Bowel Disease (IBD) as both entities involve&#xD;
      specific therapeutic management strategies. Confocal Laser Endomicroscopy (CLE) allows on&#xD;
      demand in vivo characterization of architectural and cellular details during endoscopy. Here,&#xD;
      we assessed the efficacy of CLE to differentiate between UC and CD.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Number of participants with IBD</measure>
    <time_frame>4 years</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">105</enrollment>
  <condition>Inflammatory Bowel Diseases</condition>
  <arm_group>
    <arm_group_label>Ulcerative colitis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Crohn's disease</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endomicroscopy</intervention_name>
    <arm_group_label>Crohn's disease</arm_group_label>
    <arm_group_label>Ulcerative colitis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients with well-established diagnosis of Crohn's disease and ulcerative&#xD;
        colitis.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  equal or above 18 years of age&#xD;
&#xD;
          -  ability to provide written informed consent&#xD;
&#xD;
          -  well-established diagnosis of CD or UC&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history of IBD reclassification in the last 3 years&#xD;
&#xD;
          -  Boston Bowel Preparation Scale score's &lt; 2 in at least one of the three broad regions&#xD;
             of the colon (i.e. rectum plus left side colon, transverse colon plus left and right&#xD;
             flexures, right colon)&#xD;
&#xD;
          -  inability to provide written informed consent&#xD;
&#xD;
          -  severe uncontrolled coagulopathy&#xD;
&#xD;
          -  impaired renal function&#xD;
&#xD;
          -  pregnancy or breast feeding&#xD;
&#xD;
          -  active gastrointestinal bleeding&#xD;
&#xD;
          -  known allergy to fluorescein&#xD;
&#xD;
          -  residence in institutions&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Helmut Neumann, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Erlangen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Erlangen</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <study_first_submitted>September 9, 2014</study_first_submitted>
  <study_first_submitted_qc>September 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2014</study_first_posted>
  <last_update_submitted>September 11, 2014</last_update_submitted>
  <last_update_submitted_qc>September 11, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 12, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Erlangen-Nürnberg Medical School</investigator_affiliation>
    <investigator_full_name>Helmut Neumann</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

